If you keep up with marijuana news or if you’re just around people who are always up to speed about what’s happening in the world of cannabis, then you know that many of the cannabinoids in marijuana are extremely beneficial on a medicinal level. Well, now one of the nation’s leading and most highly respected mainstream magazines has recently published a story touting the scientific effectiveness of marijuana and its potential role in preventing and slowing Alzheimer’s disease.
We’ve talked about Alzheimer’s previously and we are always thrilled when a cure or a preventive measure is tied to cannabis. This time, however, we are totally thrilled by the source of the news: Forbes Magazine. Yes, this magazine that reports on who the richest people on the planet are and what your portfolio should really look like is sharing the story of scientific researchers who have made major breakthroughs using marijuana as their focus.
The venerable Salk Institute in San Diego, California, has been seriously looking into THC (terahydrocannabinol) and other marijuana constituents, and how they can remove the amyloid beta proteins from their lab-grown neurons. Now, that didn’t make any sense to me either – at first, because I’m not a scientist. However, I am a human being and the further I read, the more I understood that what that meant was Alzheimer’s patients accumulate the toxic protein named amyloid in their brain. And they’ve been doing it for decades. THC was shown to remove amyloid along with decreasing cellular inflammation, both of which contribute to the development of Alzheimer’s.
Professor David Schubert, senior author of the study, said, “We believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells.” This study is an important step forward in understanding some of the underlying causes of Alzheimer’s and perhaps some of the ways to prevent the disease also.
Taking precautionary steps when one is young in order to remove amyloid beta and protecting the nerve cells from inflammation is one key thing to do. Although the study points to THC and other active compounds in cannabis that might be able to assist in removing amyloid beta from nerve cells, the researchers stop short of recommending the use of marijuana to Alzheimer’s prone people. Their next step is going to be clinical trials and they want everyone to know that this marijuana study was “promising but not actionable.” That, of course, is shorthand for “Go to you dispensary now! Do not stop at GO, do not collect $200. We think that’s a grand idea – thanks to Forbes Magazine.